Frontier Inflammasome Therapeutics Pty Ltd ABN Report

Frontier Inflammasome Therapeutics Pty Ltd (ABN 33 658 548 657) an Australian Private Company with an address in Queensland has had an active ABN from Monday, 4th April 2022 and is registered for GST.

Name:
Frontier Inflammasome Therapeutics Pty Ltd

ABN:
33 658 548 657

Status:
ABN Active from 4 April 2022

Type:
Australian Private Company
ACN:
658 548 657

GST:
Registered for GST from 4 April 2022

Location:
Brisbane, Southern Suburbs, QLD, 4072

ABN Updated:
15 August 2024
ASCENZO GROUP PTY LTD
MANPREET KAUR

ABN Report ™ - Qpzm - Twit Solutions Pty LTD 2025 - Latest ABN Updates - Privacy Policy - Terms of Use - Why is my public business information here?

The information provided on ABN Report is not legal or professional advice. The information on this site is based on public information that has been obtained from Australian Business Register (ABR) www.abr.gov.au. If you would like to remove your details please contact ABR about Suprressing your ABN details and ABN Report will be automatically updated accordingly. Neither the Registrar of the ABR nor the Commonwealth nor this website guarantee that the information available through this service (including search results) is accurate, up to date, complete or accept any liability arising from the use of or reliance upon this site.